The effect of pharmacological supplementation with vitamin C on low-density lipoprotein oxidation

British Journal of Clinical Pharmacology

Volumn 44, Issue 1, 1997, Pages 94-97

  Wen, Y ^a   Cooke, T ^b   Feely, J ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

Antioxidant; Atherosclerosis; Free radical; Lipid peroxidation; Vitamins C and E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; COPPER; FREE RADICAL; GLUTATHIONE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; ERYTHROCYTE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030851336     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00623.x     Document Type: Article

References (28)

1. Stamler J, Wentworth D, Neaton JD. For the MRFIT Research Group: Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? JAMA 1986; 256: 2823-2828.
2. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-798.
3. Keaney JF, Frei B. Antioxidant protection of low-density lipoprotein and its role in the prevention of atherosclerotic vascular disease. In Natural antioxidants in human health and disease. ed Frei B, California; Academic Press. 1994: 303-351.
4. Jessup W, Rankin SM, De Whalley CV, Hoult JRS, Scott J, Leake DS. α-tocopherol consumption during low-density-lipoprotein oxidation. Biochem J 1990; 265: 399-405.
5. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 1991; 53: 314S-321S.
6. Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M, Ludin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 1993; 57(suppl): 787S-797S.
7. Jialal I, Vega G, Grundy SM. Physiologic levels of ascorbate inhibit the oxidative modification of LDL. Atherosclerosis 1990; 82: 185-191.
8. Retsky KL, Freeman MW, Frei B. Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions. J Biol Chem 1993; 268: 1304-1309.
9. Packer L. Vitamin C cycle and benefits to health. In Active oxygens, lipid peroxides, and antioxidants. eds Yagi K, Japan Sci Soc Press, Boca Raton, 1993: 247-262.
10. Chung BH, Segrest JP, Ray MJ. Single vertical spin gradient ultracentrifugation. Methods Enzymol 1986; 128: 181-209.
11. Markwell MAK, Haas S, Tolbert NE, Bieber LL. Protein determination in membrane and lipoprotein samples: manual and automated procedures. Methods Enzymol 1981; 72: 296-303.
12. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-310.
13. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun 1988; 6: 67-75.
14. Wong SHY, Knight JA, Hopfer SM, Zaharia O, Leach CN, Sunderman FW. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 1987; 33: 214-220.
15. Dieber-Rotheneder M, Puhl W, Waeg G, Striegl G, Esterbauer H. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low-density lipoproteins and resistance to oxidation. J Lipid Res 1991; 32: 1325-1332.
16. Sierra C, Pastor MC, De Ramon M. Liquid chromatography determination of α-tocopherol in erythrocytes. Clin Chim Acta 1992; 208: 119-126.
17. Omaye S, Turnbull J, Sauberlich HE. Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 1979; 62: 3-12.
18. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963; 61: 882-888.
19. Frei B, Stocker R, Ames BN. Antioxidant defences and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988; 85: 9748-9752.
20. Frei B. Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 1991; 54: 1113S-1118S.
21. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification. Free Rad Biol Med 1992; 13: 341-390.
22. Knight JA, Smith SE, Kinder VE, Anstall HB. Reference intervals for plasma lipoperoxides: age-, sex-, and specimen-related variations. Clin Chem 1987; 33: 2289-2291.
23. Constantinescu A, Han D, Packer L. Vitamin E recycling in human erythrocyte membranes. J Biol Chem 1993; 268: 10906-10913.
24. Akerboom TPM, Sies H. Assay of glutathione, glutathione disulfide, and glutathione mixed disulfide in biological samples. In Detoxication and drug metabolism: Conjugation and related systems. eds W Jaakoby, Methods in Enzymology 1981; 77: 373-382.
25. Johnston CS, Meyer CG, Srilakshmi JC. Vitamin C elevates red cell glutathione in healthy adults. Am J Clin Nutr 1993; 58: 103-105.
26. Martensson J, Meister A. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: ascorbate spares glutathione and protects. Proc Natl Acad Sci USA 1991; 88: 4656-4660.
27. Fuller CJ, Grundy SM, Norkus EP, Jialal I. Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers. Atherosclerosis 1996; 119: 139-150.
28. Frei B, Gaziano JM. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J Lipid Res 1993; 34: 2135-2145.